Csg Smart Science&Technology Co R&D Expenses
The Research & Development Expenses of Csg Smart Science&Technology Co (300222.SZ) as of Oct 14, 2026 is 172.53 M CNY. In the previous year, Research & Development Expenses was 194.07 M CNY — a change of -11.10% (lower).
Get this data via API
Financial Data API
R&D Expenses
172.53 MCNY
YoY
-11.10%
Last updated:
The Csg Smart Science&Technology Co R&D Expenses history
3 Years
10 Years
25 Years
Max
| YEAR | R&D Expenses | YoY |
|---|---|---|
| 172.53 MCNY | -11.10% | |
| 194.07 MCNY | -25.28% | |
| 259.73 MCNY | +17.11% | |
| 221.79 MCNY | +0.03% | |
| 221.71 MCNY | +14.63% | |
| 193.41 MCNY | -17.30% | |
| 233.85 MCNY | +22.62% | |
| 190.72 MCNY | +38.75% | |
| 137.45 MCNY | +28.19% | |
| 107.23 MCNY | +54.65% | |
| 69.33 MCNY | +64.58% | |
| 42.13 MCNY | — |
Csg Smart Science&Technology Co Stock analysis
Frequently Asked Questions about Csg Smart Science&Technology Co stock
Research & Development Expenses of Csg Smart Science&Technology Co is 172.53 M CNY in 2025.
Research & Development Expenses of Csg Smart Science&Technology Co changed from 194.07 M CNY to 172.53 M CNY, representing a -11.10% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Research & Development Expenses Csg Smart Science&Technology Co since 2006 – with annual values, charts, and detailed analysis.
R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.
Research & Development Expenses's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Csg Smart Science&Technology Co historically and in real time.
Income Statement — Csg Smart Science&Technology Co
All Key Metrics — Csg Smart Science&Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth